Why are we doing so badly with the control of hypertension? Poor compliance is only part of the story

Journal of Clinical Hypertension

Volumn 3, Issue 3, 2001, Pages 179-182

  Pickering, T G ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; PLACEBO;

ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; DISEASE CONTROL; DRUG EFFICACY; HEALTH CARE SYSTEM; HEALTH SURVEY; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MORTALITY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PHYSICIAN ATTITUDE; PROGNOSIS; RISK ASSESSMENT; SIDE EFFECT; STROKE; TREATMENT FAILURE;

EID: 0034955133     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2001.00465.x     Document Type: Article

References (22)

1. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991
2. Sex differences in awareness and control of hypertension in France
3. Treatment of high blood pressure in Germany
4. Limiting factors in the control of BP: Why is there a gap between theory and practice?
5. Introduction
6. Poor adherence to placebo or amiodarone therapy predicts mortality: Results from the CAMIAT study. Canadian myocardial infarction arrhythmia trial
7. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project
8. Treatment adherence and risk of death after a myocardial infarction
9. Compliance with cardiovascular disease prevention strategies: A review of the research
10. How often is medication taken as prescribed? A novel assessment technique
11. Compliance declines between clinic visits
12. Use of electronic pill boxes to assess risk of poor treatment compliance: Results of a large-scale trial
13. Poor adherence to hypertension therapy: Whose Responsibility is it?
14. Electronic compliance monitoring in resistant hypertension: The basis for rational therapeutic decisions
15. Stages of change and decisional balance for 12 problem behaviors
16. Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure
17. Effectiveness of interventions to improve patient compliance: A meta-analysis
18. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications
19. Improvement of medication compliance in uncontrolled hypertension
20. The heterogeneity of hypertension: Why doesn't every patient respond to every antihypertensive drug?
21. Inadequate management of blood pressure in a hypertensive population
22. Baseline characteristics and early blood pressure control in the CONVINCE Trial